Average Co-Inventor Count = 2.56
ph-index = 17
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. University of Michigan (26 from 3,381 patents)
2. Genzyme Corporation (4 from 789 patents)
3. Craig Siegel (0 patent)
4. David J. Harris (0 patent)
5. Carol Anne Nelson (0 patent)
6. Diane Copeland (0 patent)
7. Bradford H. Hirth (0 patent)
8. James A. Shayman (0 patent)
26 patents:
1. 11220479 - Glucosylceramide synthase inhibitors and therapeutic methods using the same
2. 10202340 - Glucosylceramide synthase inhibitors and therapeutic methods using the same
3. 10111937 - Method of reducing accumulation of intracellular tingible body macrophages
4. 9309553 - Lysosomal phospholipase A2 (LPLA2) activity as a therapeutic target for treating systemic lupus erythematosus
5. 8961959 - Glucosylceramide synthase inhibitors and therapeutic methods using the same
6. 8052970 - Lysosomal phospholipase A2 (LPLA2) activity as a diagnostic and therapeutic target for identifying and treating systemic lupus erythematosis
7. 7615573 - Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors
8. 7582442 - Methods and compositions for using aleveolar macrophage phospholipase A2
9. 7335681 - Amino ceramide-like compounds and therapeutic methods of use
10. 7319015 - Methods and compositions for using alveolar macrophage phospholipase A2
11. 7253185 - Amino ceramide-like compounds and therapeutic methods of use
12. 7196205 - [object Object]
13. 7148251 - Amino ceramide-like compounds and therapeutic methods of use
14. 6916802 - Amino ceramide-like compounds and therapeutic methods of use
15. 6890949 - Amino ceramide-like compounds and therapeutic methods of use